Skip to main content
Fig. 3 | Human Genomics

Fig. 3

From: Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates

Fig. 3

Average warfarin genetic dose for participants categorized by age. The genetic dose was calculated by the IWPC algorithm, which considers age, BMI, amiodarone use, using CYP2C9 inhibitors, and the genotypes at VKORC1-1639G > A, CYP2C9*2, and CYP2C9*3. The dose was adjusted for CYP4F2 rs2108622 genotypes and represented as mg/day. The numbers represent each group's minimum, maximum, median (the line), and average dose

Back to article page

Human Genomics

ISSN: 1479-7364